Answers are grounded in this paper and cite their sources.
Edwardsiella tarda (E. tarda) is a rare human pathogen; however, the overall mortality of bacteremia is reported to be up to 50%. Here, we describe a case of cholangitis with E. tarda bacteremia who had a pancreatoduodenectomy for a locally advanced gastric cancer. He was successfully treated using a cefmetazole, a second generation cephalosporin for 14 days. To the best of our knowledge, this is the first case report about E. tarda bacteremia after biliary reconstruction.
No takes yet. Share an insight, caveat, or question.
Nishida et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: